DAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk

Dow Jones

Jan 20

1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group Merck KGaA, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. Merck KGaA is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com)

(END) Dow Jones Newswires

January 20, 2026 05:03 ET (10:03 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2604199450"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604199450\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604199450?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604199450","market":"nz","top_or_hot":-1,"title":"DAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a>, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. <a href=\"https://laohu8.com/S/MKKGY\">Merck KGaA</a> is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 20, 2026 05:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-20 18:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a>, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. <a href=\"https://laohu8.com/S/MKKGY\">Merck KGaA</a> is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 20, 2026 05:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2604199450","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604199450","pubTimestamp":1768903380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group Merck KGaA, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. Merck KGaA is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","MKKGY":"Merck KGaA"},"translate_title":"达沃斯：默克公司首席执行官表示，对美国药品价格的担忧是合理的——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MKKGY":0.9},"content_text":"1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group Merck KGaA, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. Merck KGaA is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 05:03 ET (10:03 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}